SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-21-000409
Filing Date
2021-03-25
Accepted
2021-03-25 16:30:26
Documents
15
Period of Report
2021-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e620413_8k-adma.htm   iXBRL 8-K 26190
2 e620413_ex99-1.htm EX-99.1 112577
3 GRAPHIC image_001.jpg GRAPHIC 4117
  Complete submission text file 0001193805-21-000409.txt   380467

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adma-20210325.xsd EX-101.SCH 3544
5 XBRL TAXONOMY EXTENSION DEFINITION adma-20210325_def.xml EX-101.DEF 27704
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20210325_lab.xml EX-101.LAB 36676
7 XBRL TAXONOMY EXTENSION PRESENTATION adma-20210325_pre.xml EX-101.PRE 26322
8 EXTRACTED XBRL INSTANCE DOCUMENT e620413_8k-adma_htm.xml XML 5186
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 21772761
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences